Entera Bio (ENTX) Asset Utilization Ratio (2022 - 2025)
Entera Bio's (ENTX) quarterly Asset Utilization Ratio came in at 0.0 in Q4 2025, down 88.1% YoY from 0.02 in Q4 2024, and down 62.4% on a QoQ basis from 0.01 in Q3 2025.
Entera Bio (ENTX) Asset Utilization Ratio (2022 - 2025) Analysis & Trends
Entera Bio (ENTX) has 4 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q4 2025.
- Quarterly Asset Utilization Ratio fell 88.1% year-over-year to 0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0 (down 88.1% YoY) and the FY2025 annual result came in at 0.0, down 80.66% from the prior year.
- Asset Utilization Ratio slipped to 0.0 in Q4 2025, from 0.01 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q4 2024 to a low of 0.0 in Q3 2023.
- A 4-year average of 0.01 and a median of 0.01 in 2025 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio tumbled 91.05% — and 2024, when it surged 656.23%.
- Tracing ENTX's Asset Utilization Ratio over 4 years: stood at 0.01 in 2022, then sank by 84.24% to 0.0 in 2023, then soared by 1334.66% to 0.02 in 2024, then sank by 88.1% to 0.0 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.0 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.13 |
| 10 | Entera Bio | 162.96 Mn | 151.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.02 |